Molina Healthcare Inc. (MOH)
NYSE: MOH
· Real-Time Price · USD
167.19
7.56 (4.74%)
At close: Aug 15, 2025, 3:43 PM
Molina Healthcare Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 4.5B | 4.86B | 4.66B | 4.73B | 4.35B | 4.51B | 4.85B | 5.57B | 4.91B | 4.55B | 4.01B | 4.24B | 4.31B | 4.8B | 4.44B | 4.36B | 4.61B | 4.43B |
Short-Term Investments | n/a | 4.44B | 4.33B | 4.48B | 4.35B | 4.42B | 4.26B | 4.11B | 3.89B | 3.81B | 3.5B | 3.64B | 3.57B | 2.99B | 3.2B | 2.9B | 2.24B | 1.94B |
Long-Term Investments | n/a | n/a | n/a | n/a | -131M | -3.47B | 306M | n/a | n/a | n/a | 280M | n/a | n/a | n/a | 212M | n/a | n/a | n/a |
Other Long-Term Assets | 439M | 474M | 424M | 421M | 535M | 3.87B | 98M | 386M | 367M | 361M | 81M | 428M | 412M | 402M | 179M | 284M | 279M | 275M |
Receivables | 3.87B | 3.49B | 3.3B | 3.26B | 3.23B | 3.35B | 3.1B | 2.46B | 2.38B | 2.54B | 2.3B | 2.22B | 2.24B | 2.16B | 2.18B | 1.91B | 1.86B | 1.78B |
Inventory | n/a | n/a | n/a | n/a | -7.58B | -7.86B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.75B | 472M | 487M | 4.89B | 4.75B | 4.8B | 331M | 4.44B | 4.15B | 259M | 3.78B | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 13.11B | 13.26B | 12.77B | 12.88B | 12.33B | 12.67B | 12.54B | 12.47B | 11.44B | 11.16B | 10.08B | 10.49B | 10.33B | 10.15B | 10.06B | 9.37B | 8.87B | 8.31B |
Property-Plant & Equipment | 305M | 287M | 288M | 306M | 305M | 295M | 270M | 290M | 285M | 274M | 259M | 412M | 401M | 393M | 396M | 385M | 383M | 378M |
Goodwill & Intangibles | 2.17B | 2.17B | 1.94B | 1.92B | 1.91B | 1.93B | 1.45B | 1.47B | 1.35B | 1.37B | 1.39B | 1.26B | 1.29B | 1.3B | 1.25B | 915M | 929M | 923M |
Total Long-Term Assets | 3.1B | 3.13B | 2.86B | 2.88B | 2.85B | 2.85B | 2.35B | 2.4B | 2.22B | 2.21B | 2.23B | 2.3B | 2.24B | 2.21B | 2.15B | 1.67B | 1.66B | 1.64B |
Total Assets | 16.21B | 16.39B | 15.63B | 15.76B | 15.19B | 15.51B | 14.89B | 14.87B | 13.66B | 13.37B | 12.31B | 12.79B | 12.57B | 12.36B | 12.21B | 11.03B | 10.53B | 9.95B |
Account Payables | n/a | 1.12B | 1.33B | 1.22B | 973M | 1.11B | 1.25B | 1.09B | 857M | 787M | 889M | 818M | 715M | 809M | 842M | 797M | 651M | 695M |
Deferred Revenue | 57M | 369M | 51M | 364M | 13M | 328M | 418M | 691M | 414M | 654M | 359M | 663M | 13M | 18M | 370M | 1M | 42M | 71M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 7.82B | n/a | n/a | 6.76B | n/a | n/a | 6.48B | 6.71B | 6.27B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.01B | 4.56B |
Total Current Liabilities | 7.88B | 8.15B | 7.9B | 8.34B | 7.84B | 8.51B | 8.17B | 8.49B | 7.54B | 7.61B | 6.86B | 7.24B | 7.22B | 7.04B | 7.05B | 6.07B | 5.71B | 5.32B |
Long-Term Debt | 3.56B | 3.57B | 3.12B | 2.33B | 2.18B | 2.18B | 2.18B | 2.18B | 2.18B | 2.18B | 2.18B | 2.17B | 2.17B | 2.17B | 2.17B | 2.13B | 2.13B | 2.13B |
Other Long-Term Liabilities | 167M | 347M | 120M | 122M | 122M | 124M | 124M | 121M | 122M | 88M | 104M | 118M | 126M | 134M | 140M | 95M | 101M | 112M |
Total Long-Term Liabilities | 3.73B | 3.92B | 3.24B | 2.65B | 2.51B | 2.51B | 2.51B | 2.5B | 2.5B | 2.47B | 2.5B | 2.51B | 2.52B | 2.52B | 2.53B | 2.44B | 2.45B | 2.46B |
Total Liabilities | 11.61B | 12.08B | 11.13B | 10.99B | 10.34B | 11.02B | 10.68B | 10.99B | 10.04B | 10.08B | 9.35B | 9.75B | 9.74B | 9.57B | 9.58B | 8.52B | 8.16B | 7.79B |
Total Debt | 3.56B | 3.77B | 3.12B | 2.53B | 2.38B | 2.38B | 2.38B | 2.38B | 2.38B | 2.38B | 2.39B | 2.39B | 2.39B | 2.39B | 2.39B | 2.35B | 2.35B | 2.35B |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | 4.16B | 3.9B | 4.09B | 4.33B | 4.49B | 4.19B | 3.89B | 3.67B | 3.43B | 3.12B | 2.8B | 2.94B | 2.71B | 2.66B | 2.4B | 2.3B | 2.15B | 1.97B |
Comprehensive Income | -10M | -28M | -57M | -9M | -85M | -85M | -82M | -165M | -146M | -125M | -160M | -185M | -128M | -81M | -5M | 17M | 26M | 26M |
Shareholders Equity | 4.6B | 4.31B | 4.5B | 4.77B | 4.84B | 4.49B | 4.21B | 3.88B | 3.62B | 3.29B | 2.96B | 3.04B | 2.83B | 2.79B | 2.63B | 2.52B | 2.37B | 2.16B |
Total Investments | n/a | 4.44B | 4.33B | 4.48B | 4.35B | 4.42B | 4.26B | 4.11B | 3.89B | 3.81B | 3.5B | 3.64B | 3.57B | 2.99B | 3.2B | 2.9B | 2.24B | 1.94B |